Hopper Jonathan Mark
Chief Medical Officer
Hopper Jonathan Mark has filed 7 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Hopper Jonathan Mark is listed as Chief Medical Officer at Vericel Corp. Inside the rolling window, Hopper Jonathan Mark reported no open-market purchases and 4 open-market sales totaling $564K in VCEL. The largest disclosed transaction in the window is a sale of 5,000 VCEL shares on Jun 26, 2026, worth $225K.
Companies traded
Other insiders at VCEL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$564K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 2, 2025 | VCEL | Sale | $358K |
Frequently asked questions
How many SEC Form 4 filings has Hopper Jonathan Mark made?
Hopper Jonathan Mark has filed 7 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.
Which companies does Hopper Jonathan Mark trade?
Hopper Jonathan Mark has filed SEC Form 4 disclosures for 1 company, including VCEL.
When was Hopper Jonathan Mark's most recent SEC Form 4 filing?
Hopper Jonathan Mark's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Hopper Jonathan Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hopper Jonathan Mark is listed as Chief Medical Officer.
What is Hopper Jonathan Mark's total buy and sell value in the current window?
Inside the rolling retention window, Hopper Jonathan Mark bought $0 and sold $564K based on SEC Form 4 filings.
What was Hopper Jonathan Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 VCEL shares on 2026-06-26, worth $225K, per SEC Form 4 filings.